Press Releases Isofol Medical AB

Equities

ISOFOL

SE0009581051

Market Closed - Nasdaq Stockholm Other stock markets 08:59:49 10/05/2024 pm IST			5-day change	1st Jan Change
0.658 ^SEK	-9.24%		-5.32%	-9.86%

20/02	Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
20/02	Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bulletin from annual general meeting in Isofol Medical AB (publ) held on May 8, 2024	08/05	AQ
Isofol Medical () : publishes interim report, January-March 2024	08/05	PU
Isofol Medical AB (publ) publishes interim report, January–March 2024	08/05	AQ
Isofol Medical AB (publ) publishes annual report and corporate governance report for 2023	16/04	AQ
Notice to attend the Annual General Meeting held on May 8, 2024 in Isofol Medical AB (publ)	05/04	AQ
Isofol Medical : Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin	19/03	PU
Isofol’s Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin	19/03	AQ
Isofol presents a clinical development plan for arfolitixorin	19/03	AQ
Isofol Medical : invites to investor meeting on March 19	01/03	PU
Isofol Medical AB (publ) publishes year-end report, January - December 2023	20/02	AQ
Isofol's Board of Directors decides to initiate the planning of clinical studies and will announce a strategic development plan on March 19	14/02	AQ
Isofol appoints Magnus Hurst as new Chief Financial Officer	11/01	AQ
Isofol appoints Petter Segelman Lindqvist as new CEO	09/01	AQ
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on January 4, 2024	04/01	AQ
Isofol presents additional results from laboratory tests with arfolitixorin showing supplementary effects	29/12	AQ
Isofol's board of directors announces its position on minority shareholder's proposal ahead of extraordinary general meeting	13/12	AQ
Isofol has received the first results from laboratory tests of arfolitixorin	08/12	AQ
Isofol is liquidating a subsidiary	01/12	AQ
Notice convening the Extraordinary General Meeting in Isofol Medical AB (publ) 4 January 2024	21/11	AQ
Isofol Medical AB (publ) publishes interim report, January-September 2023	10/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Isofol Medical AB

Equities

ISOFOL

SE0009581051

Press Releases

Filters